As of 2025-01-24, the Relative Valuation of Exact Sciences Corp (EXAS) is (35.42) USD. This relative valuation is based on P/E multiples. With the latest stock price at 55.13 USD, the upside of Exact Sciences Corp based on Relative Valuation is -164.2%.
The range of the Relative Valuation is (28.66) - (36.82) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.9x - 31.8x | 27.6x |
| Forward P/E multiples | 24.8x - 43.6x | 33.6x |
| Fair Price | (28.66) - (36.82) | (35.42) |
| Upside | -152.0% - -166.8% | -164.2% |
| Date | P/E |
| 2025-01-23 | -47.67 |
| 2025-01-22 | -47.38 |
| 2025-01-21 | -46.92 |
| 2025-01-17 | -44.74 |
| 2025-01-16 | -43.62 |
| 2025-01-15 | -46.28 |
| 2025-01-14 | -46.87 |
| 2025-01-13 | -50.59 |
| 2025-01-10 | -48.86 |
| 2025-01-08 | -49.01 |
| 2025-01-07 | -49.37 |
| 2025-01-06 | -49.98 |
| 2025-01-03 | -49.50 |
| 2025-01-02 | -49.22 |
| 2024-12-31 | -48.59 |
| 2024-12-30 | -48.60 |
| 2024-12-27 | -49.76 |
| 2024-12-26 | -49.70 |
| 2024-12-24 | -50.25 |
| 2024-12-23 | -50.96 |
| 2024-12-20 | -51.36 |
| 2024-12-19 | -48.52 |
| 2024-12-18 | -49.62 |
| 2024-12-17 | -52.20 |
| 2024-12-16 | -52.53 |
| 2024-12-13 | -52.96 |
| 2024-12-12 | -54.05 |
| 2024-12-11 | -54.61 |
| 2024-12-10 | -53.25 |
| 2024-12-09 | -53.44 |
| 2024-12-06 | -54.01 |
| 2024-12-05 | -54.14 |
| 2024-12-04 | -55.46 |
| 2024-12-03 | -52.37 |
| 2024-12-02 | -53.34 |
| 2024-11-29 | -53.68 |
| 2024-11-27 | -53.34 |
| 2024-11-26 | -51.97 |
| 2024-11-25 | -47.68 |
| 2024-11-22 | -45.75 |
| 2024-11-21 | -45.89 |
| 2024-11-20 | -45.57 |
| 2024-11-19 | -46.62 |
| 2024-11-18 | -42.84 |
| 2024-11-15 | -42.66 |
| 2024-11-14 | -44.04 |
| 2024-11-13 | -43.87 |
| 2024-11-12 | -43.37 |
| 2024-11-11 | -44.39 |
| 2024-11-08 | -44.52 |